Celsion Corporation Reports Third Quarter 2019 Financial Results and Provides Business Update
November 14, 2019 16:05 ET
|
Celsion CORP
Independent Data Monitoring Committee (iDMC) Unanimously Recommends Continuation of Phase III OPTIMA Study at First Pre-Planned Efficacy AnalysisIndependent Data Safety Monitoring Board (DSMB)...
Net Element Reports Third Quarter 2019 Financial Results and Provides Business Update
November 14, 2019 08:30 ET
|
Net Element, Inc.
MIAMI, Nov. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports...
IBA DÉCLARATION INTERMÉDIAIRE - TROISIÈME TRIMESTRE 2019
November 14, 2019 00:30 ET
|
IBA SA
Louvain-la-Neuve, Belgique, le 14 novembre 2019 - IBA (Ion Beam Applications S.A., EURONEXT), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, publie...
Iba Business Update – Third Quarter 2019
November 14, 2019 00:30 ET
|
IBA SA
Louvain-la-Neuve, Belgium, 14 November, 2019 - IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces its business update...
ObsEva Announces Third Quarter 2019 Financial Results
November 07, 2019 01:10 ET
|
ObsEva SA
– Reports Update on Three Women’s Health Product Candidates – – Focusing on Phase 3 Programs for Linzagolix and the Phase 2 Program for OBE022 – – Company to Host Conference Call/Webcast...
PAVmed to Hold Business Update Conference Call on November 21, 2019
November 06, 2019 09:30 ET
|
PAVmed Inc.
NEW YORK, Nov. 06, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
BioCorRx Announces Capital Restructuring and Provides Business Update
October 07, 2019 08:30 ET
|
BioCorRx, Inc.
ANAHEIM, CA, Oct. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
PAVmed Successfully Completes Clinical Safety Study Procedures for CarpX™ 510(k) Re-submission
August 15, 2019 09:30 ET
|
PAVmed Inc.
All 20 patients underwent successful CarpX procedures while passing primary effectiveness endpoint, with all follow-up patients to date passing primary safety endpoint NEW YORK, Aug. 15, 2019 ...
Auris Medical Provides Business Update and Reports First Half 2019 Financial Results
August 15, 2019 07:00 ET
|
Auris Medical AG
Hamilton, Bermuda, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Enrollment of first patient in TRAVERS Phase 2 trial with AM-125 in acute vertigoEnrollment completed in Phase 1b trial with AM-201 in...
Celsion Corporation Reports Second Quarter 2019 Financial Results and Provides Business Update
August 14, 2019 16:30 ET
|
Celsion CORP
First Pre-Planned Efficacy Analysis of the Phase III OPTIMA Study Planned for Mid-October Strong Balance Sheet Plus the Non-Dilutive Sale of $4 Million of New Jersey State Net Operating...